Time-Restricted Eating Cut Standing Heart Rate by 11 BPM in POTS Patients: What the Research Shows

Time-Restricted Eating Cut Standing Heart Rate by 11 BPM in POTS Patients: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

Note: PubMed's search interface was inaccessible at generation time. This article was written from publicly indexed abstract and press coverage of the study (Scientific Reports, Oct 2025; PMID 41038948; ClinicalTrials.gov NCT05409651), cross-checked across multiple sources — not from the full-text PDF.

What This Study Looked At

Postural orthostatic tachycardia syndrome (POTS) causes the heart to race abnormally fast when a person stands up, along with dizziness, brain fog, and crushing fatigue — symptoms that overlap with what many people already notice around dizziness and lightheadedness during fasting and heart palpitations during a fast. Researchers at UC San Diego wanted to know whether time-restricted eating (TRE) — compressing food intake into a set daily window — could actually improve POTS symptoms rather than worsen them, since POTS is linked to insulin resistance and autonomic nervous system dysfunction. This builds on related work on fasting and blood pressure.

Who Was Studied

Participant profile: All 20 participants met diagnostic criteria for POTS (a heart rate increase of 30 beats per minute or more within 10 minutes of standing). At baseline, all had a habitual eating window of 12 hours or longer per day — meaning none were already practicing meaningful time restriction before the study. Detailed age and sex breakdown were not published in the available public abstract, though POTS overwhelmingly affects women of reproductive age in the broader clinical literature.

How TRE worked in this study: After two weeks of simply monitoring their normal eating pattern, participants narrowed their daily eating window to roughly 8–10 hours for 12 straight weeks. Outside that window, only water and non-caloric beverages were allowed. Participants stayed on their existing POTS medications throughout, so the study measured what TRE added on top of standard treatment rather than as a replacement for it.

What the Researchers Found

Standing Heart Rate

• The exaggerated heart rate spike that defines POTS — the jump in beats per minute when moving from lying or sitting to standing — dropped by an average of 11 beats per minute after 12 weeks of TRE.
• This is the study's headline finding: a meaningful, statistically significant improvement in the core physiological marker used to diagnose and track POTS.

Quality of Life and Symptoms

• POTS symptom severity: significantly improved (p<0.0001) — the largest effect size in the study
• Physical functioning: significantly improved (p=0.02)
• Energy and fatigue: significantly improved (p<0.01) — notable because crushing fatigue is one of the most disabling parts of living with POTS

Mitochondrial Function

• Plasma markers of mitochondrial-derived ATP increased following the TRE intervention, consistent with animal research showing TRE improves mitochondrial efficiency.
• This gives a plausible biological mechanism for the symptom improvements, rather than the effect being purely subjective.

What Did Not Change

• Participants continued their pre-existing POTS medications throughout the study; the design cannot isolate how much of the improvement came from TRE alone versus medication plus TRE together.
• Detailed body weight and lean mass changes were not a primary focus of the published results and were not reported in the available abstract.

What the Researchers Concluded

The researchers concluded that a 12-week time-restricted eating intervention, layered on top of standard background medical therapy, significantly improved standing heart rate, symptom burden, and quality of life in people with POTS, and proposed improved mitochondrial function as a contributing mechanism.

What This Means If You Fast

• This is not a "does fasting cause POTS" study — it's the opposite. The results suggest TRE may help calm an overactive heart-rate response in people who already have POTS, not trigger it.
• The eating window used was moderate, not extreme. Participants ate within an 8–10 hour window — similar to a standard 16:8 protocol — not multi-day fasting, which is a meaningfully different intervention.
• Electrolytes and hydration still matter. POTS management already leans heavily on fluid and salt intake; anyone combining TRE with a POTS diagnosis should keep following guidance like electrolytes during intermittent fasting rather than assuming fasting alone solves hydration needs.
• This does not replace medical treatment. Every participant stayed on their existing POTS medications — TRE was tested as an addition, not a substitute.
• The heart-rate reduction is clinically meaningful, not marginal. An 11 bpm average drop in the standing heart rate response is a substantial physiological change for a condition defined by that exact measurement.
• If you have POTS or a diagnosed autonomic condition, loop in your doctor before changing your eating window — this was a supervised pilot study, not a general how-to.

Study Limitations

• No control group. This was a single-arm, open-label pilot study — everyone received TRE, with no comparison group eating on their normal schedule over the same 12 weeks, which limits how confidently the improvement can be attributed to TRE alone versus natural symptom fluctuation or placebo response.
• Very small sample size (n=20). A pilot study of this size is meant to test feasibility and generate a signal for larger trials, not to provide definitive proof of effect.
• Open-label design. Both participants and researchers knew the treatment being given, which can inflate self-reported quality-of-life improvements.
• Short-to-moderate duration (12 weeks). Long-term durability of the heart-rate and symptom improvements beyond the study period is unknown.
• Specific population. All participants had a habitual eating window of 12+ hours at baseline and were on background POTS medication; results may not generalize to people already eating in a shorter window or off medication.
• Demographic detail limited. Age range and sex breakdown were not available in the public abstract used for this summary.

Source

Dzotsi M, Strohm E, Varshney N, et al. (2025). Time-restricted eating improves quality of life, heart rate, and mitochondrial function in patients with postural orthostatic tachycardia syndrome: An open-label pilot study. Scientific Reports, 15(1):34345. PMID: 41038948

Frequently Asked Questions

Can intermittent fasting help POTS symptoms?

In this 2025 pilot study of 20 people with POTS, 12 weeks of time-restricted eating (an 8–10 hour daily eating window) significantly reduced the abnormal heart rate spike on standing by an average of 11 bpm and improved quality-of-life scores, on top of participants' existing medication.

Does fasting make POTS worse?

This study did not find that time-restricted eating worsened POTS; heart rate response to standing and overall symptom severity both improved significantly (p<0.0001 for symptom severity). However, POTS varies a lot person to person, so anyone with the condition should introduce a fasting window gradually and under medical guidance.

How long was the eating window in the POTS study?

Participants ate within roughly an 8–10 hour daily window, similar to a standard 16:8 schedule, for 12 weeks after a 2-week baseline period.

Did people in the study stop taking POTS medication?

No. All participants continued their existing background POTS medical therapy throughout the study — time-restricted eating was tested as an addition to treatment, not a replacement for it.

Why might time-restricted eating help a condition involving heart rate and the nervous system?

The researchers found increased markers of mitochondrial-derived ATP after the intervention, suggesting improved mitochondrial and autonomic function as a possible mechanism, consistent with prior TRE research on cardiometabolic and inflammatory markers.

Related Research and Articles

• Why do I feel dizzy or lightheaded while intermittent fasting?
• Heart palpitations during fasting: what's normal and what's not
• Can intermittent fasting lower blood pressure?
• Electrolytes and intermittent fasting: what you need to know
• What is the 16:8 intermittent fasting protocol?
• 16:8 intermittent fasting and blood pressure: what the research shows
• Time-restricted eating: the complete guide

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.